Autism Spectrum Disorder Trial, Recruiting NCT07501286 Sponsor: Nicole Matthews, Ph.D. Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07501286
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adolescents who are between 13 and 18 years old
  • People who have a formal diagnosis of Autism Spectrum Disorder (ASD), confirmed by a clinical or educational assessment report that can be shared with the research team
  • People who are willing to be placed into either an active treatment group or a waitlist group (where treatment starts later) through a random process
  • People who are able to attend at least 7 out of 8 group sessions
  • Adolescents and their parent or caregiver must both speak English, as all materials and sessions are conducted in English

Who may not be able to join:

  • People who are non-verbal, as the intervention requires verbal participation
  • People with an IQ score below 70, as the program was designed for those without an intellectual disability
  • People with a physical disability or another condition that could prevent participation in weekly 90-minute video call group sessions (for example, selective mutism or aggressive behaviour)
  • People who are currently experiencing active thoughts of suicide

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicole Matthews, Ph.D., Southwest Autism Research & Resource Center

Phone: (480) 603-3285

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nicole Matthews, Ph.D.
Registry
ClinicalTrials.gov
Start date
24 March 2026
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Change from Baseline in Children's Depression Inventory (CDI) Scores; Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) Scores; Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov